InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+69.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Nathanielsz James Andrew, Chief Financial Officer. Insider active across 1 company, notably Propanc Biopharma, Inc.. Aggregated, 2 reports have been recorded. History available since 17 August 2021. The latest transaction was disclosed on 17 August 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
5,928,000 shares0Common stock, par value $0.001SEC:0001493152-21-020758:0
5,928,000 shares0Common stock, par value $0.001SEC:0001493152-21-020758
2 of 2 declarations
About Nathanielsz James Andrew
James Andrew Nathanielsz is the CEO and CFO at Propanc Biopharma, Inc. In this dual role, he oversees the company's operations as well as its financial management. His expertise is crucial to ensure the viability and growth of Propanc.
